QuantCapitol. Congressional Trading Intelligence

Updated 2026-11-05 08:10 UTC · Public disclosure record

GRXTICKER

Gabelli Healthcare & Wellnessrx Trust

INSUFFICIENT DATA stock

Congress has disclosed 1 buy and 1 sell of GRX (Gabelli Healthcare & Wellnessrx Trust) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.

Activity Congressional Activity

1
Buy
1
Sell
+0
Net
1
Active politicians
Price & congressional trades
Buy Sell

2 trades Recent Congressional Trades

Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.

PoliticianChamberTypeOwnerDateDisclosure lagPrice move
in that
window
AmountScoreSource
Raúl Grijalva House SELL Spouse 2016-09-19 0 days — $1K–$15K 40.4 ↗ filing
Raúl Grijalva House BUY Spouse 2015-04-28 16 days — $1K–$15K 75.9 ↗ filing

Corporate insiders · SEC Form 4 Insider Activity

What the company's own officers and directors did in GRX — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →

0
Congress trades with insider convergence
0
…with insider divergence
123
Insider open-market trades

Of the congressional trades in GRX, 0 coincided with corporate insiders moving the same way within 60 days, and 0 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.

DateInsiderRoleTypeSizeSource
2026-11-02 Saba Capital Management, L.P. Other BUY $12K ↗ EDGAR
2026-10-30 Saba Capital Management, L.P. Other BUY $103K ↗ EDGAR
2026-10-29 Saba Capital Management, L.P. Other BUY $5K ↗ EDGAR
2026-10-27 Saba Capital Management, L.P. Other BUY $3K ↗ EDGAR
2026-10-26 Saba Capital Management, L.P. Other BUY $13K ↗ EDGAR
2026-10-15 Saba Capital Management, L.P. Other BUY $2K ↗ EDGAR
2026-10-08 Saba Capital Management, L.P. Other BUY $4K ↗ EDGAR
2026-10-07 Saba Capital Management, L.P. Other BUY $28K ↗ EDGAR
2026-10-06 Saba Capital Management, L.P. Other BUY $42K ↗ EDGAR
2026-10-05 Saba Capital Management, L.P. Other BUY $17K ↗ EDGAR
2026-10-02 Saba Capital Management, L.P. Other BUY $5K ↗ EDGAR
2026-10-01 Saba Capital Management, L.P. Other BUY $54K ↗ EDGAR
2026-09-30 Saba Capital Management, L.P. Other BUY $5K ↗ EDGAR
2026-09-11 Saba Capital Management, L.P. Other BUY $4K ↗ EDGAR
2026-09-03 Saba Capital Management, L.P. Other BUY $5K ↗ EDGAR
2026-08-27 Saba Capital Management, L.P. Other BUY $44K ↗ EDGAR
2026-08-21 Saba Capital Management, L.P. Other BUY $72K ↗ EDGAR
2026-08-19 Saba Capital Management, L.P. Other BUY $244K ↗ EDGAR
2026-08-14 Saba Capital Management, L.P. Other BUY $12K ↗ EDGAR
2026-08-11 Saba Capital Management, L.P. Other BUY $2K ↗ EDGAR
2026-01-12 GABELLI MARIO J Director BUY $36K ↗ EDGAR
2026-01-12 GABELLI MARIO J Director BUY $10K ↗ EDGAR
2026-01-08 GABELLI MARIO J Director BUY $9K ↗ EDGAR
2025-12-26 GABELLI MARIO J Director BUY $1.0M ↗ EDGAR
2025-12-26 GABELLI MARIO J Director BUY $5.0M ↗ EDGAR

Combined timeline — Congress & insiders

Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.

DateWhoTypeSize
◆ insider 2026-11-02 Saba Capital Management, L.P. Other BUY $12K
◆ insider 2026-10-30 Saba Capital Management, L.P. Other BUY $103K
◆ insider 2026-10-29 Saba Capital Management, L.P. Other BUY $5K
◆ insider 2026-10-27 Saba Capital Management, L.P. Other BUY $3K
◆ insider 2026-10-26 Saba Capital Management, L.P. Other BUY $13K
◆ insider 2026-10-15 Saba Capital Management, L.P. Other BUY $2K
◆ insider 2026-10-08 Saba Capital Management, L.P. Other BUY $4K
◆ insider 2026-10-07 Saba Capital Management, L.P. Other BUY $28K
◆ insider 2026-10-06 Saba Capital Management, L.P. Other BUY $42K
◆ insider 2026-10-05 Saba Capital Management, L.P. Other BUY $17K
◆ insider 2026-10-02 Saba Capital Management, L.P. Other BUY $5K
◆ insider 2026-10-01 Saba Capital Management, L.P. Other BUY $54K
◆ insider 2026-09-30 Saba Capital Management, L.P. Other BUY $5K
◆ insider 2026-09-11 Saba Capital Management, L.P. Other BUY $4K
◆ insider 2026-09-03 Saba Capital Management, L.P. Other BUY $5K
◆ insider 2026-08-27 Saba Capital Management, L.P. Other BUY $44K
◆ insider 2026-08-21 Saba Capital Management, L.P. Other BUY $72K
◆ insider 2026-08-19 Saba Capital Management, L.P. Other BUY $244K
◆ insider 2026-08-14 Saba Capital Management, L.P. Other BUY $12K
◆ insider 2026-08-11 Saba Capital Management, L.P. Other BUY $2K
◆ insider 2026-01-12 GABELLI MARIO J Director BUY $36K
◆ insider 2026-01-12 GABELLI MARIO J Director BUY $10K
◆ insider 2026-01-08 GABELLI MARIO J Director BUY $9K
◆ insider 2025-12-26 GABELLI MARIO J Director BUY $1.0M

FAQ Common questions

How much has Congress traded GRX?

1 disclosed buys and 1 sells of GRX (Gabelli Healthcare & Wellnessrx Trust) appear in official congressional financial disclosures.

Is it legal for members of Congress to trade GRX?

Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.

Where does this data come from?

Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.

About this data. Sourced from official House Clerk and Senate eFD financial disclosures (Senate via a maintained community mirror — see project documentation). Transaction amounts are reported as ranges, not exact figures. Interest scores, consensus labels, and backtested performance are proprietary analytical calculations based on public data and are not investment advice. Backtested performance is a hypothetical simulation, not actual portfolio performance.